Cuban uterine manipulator, new device for the hysterectomy totally laparoscopic.

计划入组 100 人

VOLT CE Mark Study

计划入组 300 人 · 首次发布于 2023 年 10 月 30 日

FOCALFLEX (CE Mark) Study

计划入组 150 人 · 首次发布于 2024 年 2 月 22 日

Lumino-mark Inj.

OpRegen-Plus

Euvichol-Plus

Mark Cuban Cost Plus Drug Company, PBC

United States

Stein Mark

Israel

MARK STANCZYK

Australia

Mark Cuban Cost Plus Drug Company Expands Affordable Healthcare Access Through Strategic Partnerships

Serve You Rx Adds Two Ustekinumab Biosimilars to Formulary, Offering Up to 96% Cost Savings

Mark Cuban's Cost Plus Drugs Adds Starjemza Biosimilar to Specialty Medicine Portfolio